Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

New modular, spring-like devices maximize the work of live muscle fibers so they can be harnessed to power biohybrid bots.

The longtime academic leader of the Harvard-MIT Program in Health Sciences and Technology reflects on her time spent guiding students at the intersection of medicine and engineering.

An MRI method purported to detect neurons’ rapid impulses produces its own misleading signals instead, an MIT study finds.

MIT researchers plan to search for proteins that could be used to measure electrical activity in the brain.

MIT senior Daisy Wang interweaves biological engineering and women’s and gender studies as a way to address social problems.

MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.

Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

Marcos Berríos ’06, Christina Birch PhD ’15, and Christopher Williams PhD ’12, now eligible for spaceflight assignments, encourage MIT students to apply for the next astronaut class.

Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.

Materials from MIT’s Distinctive Collections reveal stories of women at the Institute.

New MIT offering brings a multidisciplinary approach to tackling substance use disorder through biomedical device innovation.

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

Award honors “scientists who have made a transformational contribution toward the improvement of human health.”

The sticky, wearable sensor could help identify early signs of acute liver failure.

A new microscopy technique that enables high-resolution imaging could one day help doctors diagnose and treat brain tumors.

Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

Faculty and researchers across MIT’s School of Engineering receive many awards in recognition of their scholarship, service, and overall excellence.

Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.

A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.

MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.

MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.

Cancer nanomedicine was on display at the 2023 White House Demo Day.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.

A new method enables optical devices that more closely match their design specifications, boosting accuracy and efficiency.

Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.

The realistic model could aid the development of better heart implants and shed light on understudied heart disorders.

Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.

Using fluorescent labels that switch on and off, MIT engineers can study how molecules in a cell interact to control the cell’s behavior.

By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.

Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease.

Driven by deeply personal experiences, three entrepreneurs find inspiration from MIT to empower patients and change their lives.

MIT researchers will partner on interdisciplinary research in human biology and disease.

Glyco enthusiasts from MIT and beyond recently gathered in Bartos Theatre to enjoy presentations of the latest advancements in glycobiology research.

Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.

Actuating grafts appears to turn on cell signals related to the growth of new blood vessels and nerves, a promising finding for restoring mobility in muscle lost through disease or trauma.

The 15th Kendall Square Association annual meeting explored new and old aspects of the neighborhood.

The vibrating platform could be useful for growing artificial muscles to power soft robots and testing therapies for neuromuscular diseases.

The fibers could help with testing treatments for nerve-related pain.

Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.

By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.